Clinical Management of Spinal Tumor: Surgical Treatment, Radiotherapy and Systemic Therapy

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 613

Special Issue Editors


E-Mail Website
Guest Editor
Department of Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy
Interests: spinal surgery; primary spine tumors; spinal metastases; degenerative spine disease

E-Mail Website
Guest Editor
Department of Spine Surgery, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy
Interests: regenerative medicine; patient safety; quality of life
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Spinal tumors range from relatively rare primary tumors to the increasingly common metastatic disease of the spine. Although primary tumors of the spine are rare (<10% of spinal tumors), the number of patients with metastatic disease to the spine is substantial. Spinal metastases will be found in approximately 20% of all patients diagnosed with cancer (and in ≈70% of those with metastatic disease). The workup of the new spinal lesion can be challenging, and improper workup/treatment can lead to poor outcomes. By contrast, metastatic disease of the spine is relatively common, but multidisciplinary management is relevant for this pathology.

This Special Issue aims to provide an overview of current treatments for spinal tumors, both primary and metastatic, concerning surgery, radiotherapy, and systemic therapy, with a particular focus on innovative therapeutic pathways and multidisciplinary approaches.

Original research articles are especially requested, though a limited number of reviews can be accepted.

Dr. Riccardo Ghermandi
Dr. Cristiana Griffoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • primary spinal tumors
  • metastatic spinal disease
  • surgery
  • radiotherapy
  • systemic therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 4481 KiB  
Article
Electrochemotherapy in Aggressive Hemangioma of the Spine: A Case Series and Narrative Literature Review
by Giuseppe Tedesco, Luigi Emanuele Noli, Cristiana Griffoni, Riccardo Ghermandi, Giancarlo Facchini, Giuliano Peta, Nicolas Papalexis, Emanuela Asunis, Stefano Pasini and Alessandro Gasbarrini
J. Clin. Med. 2024, 13(5), 1239; https://0-doi-org.brum.beds.ac.uk/10.3390/jcm13051239 - 22 Feb 2024
Viewed by 487
Abstract
(1) Background: this case series and literature review aims to evaluate the efficacy and safety of electrochemotherapy in the management of aggressive spinal hemangiomas, presenting two distinct cases. (2) Methods: we present two cases of spinal aggressive hemangioma which were refractory to conventional [...] Read more.
(1) Background: this case series and literature review aims to evaluate the efficacy and safety of electrochemotherapy in the management of aggressive spinal hemangiomas, presenting two distinct cases. (2) Methods: we present two cases of spinal aggressive hemangioma which were refractory to conventional treatments and underwent electrochemotherapy. Case 1 involves a 50-year-old female who presented with an aggressive spinal hemangioma of L1, who previously underwent various treatments including surgery, radio-chemotherapy, and arterial embolization. Case 2 describes a 16-year-old female with a T12 vertebral hemangioma, previously treated with surgery and stabilization, who faced limitations in treatment options due to her young age and the location of the hemangioma. (3) Results: in Case 1, electrochemotherapy with bleomycin was administered following the failure of previous treatments and resulted in the reduction of the lesion size and improvement in clinical symptoms. In Case 2, electrochemotherapy was chosen due to the risks associated with other treatments and was completed without any adverse events. Both cases demonstrated the potential of electrochemotherapy as a viable treatment option for spinal hemangiomas, especially in complex or recurrent cases. (4) Conclusions: electrochemotherapy with bleomycin is a promising treatment for aggressive spinal hemangiomas when conventional therapies are not feasible or have failed. Further research is needed to establish definitive protocols and long-term outcomes of electrochemotherapy in spinal hemangioma management. Full article
Show Figures

Figure 1

Back to TopTop